5α-Reductase Inhibitors in Prostate Cancer: An Overview

    April 2017 in “ Austin Journal of Cancer and Clinical Research ”
    Neelima D. Passi
    Studysummary This article reviews the role and controversies of 5α-reductase inhibitors like finasteride and dutasteride in managing prostate cancer, without presenting new research results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on austinpublishinggroup.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Role of 5 Alpha-Reductase Inhibitors in the Management of Prostate Cancer Clinical interventions in aging · 2006
    2. Dutasteride: A Review of Current Data on a Novel Dual Inhibitor of 5-Alpha Reductase PubMed · 2005
    3. 5α-Reductase: History And Clinical Importance PubMed Central · 2004
    4. Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men The Journal of Clinical Endocrinology and Metabolism · 1992
    5. Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men The Journal of Clinical Endocrinology and Metabolism · 1992